Viewing Study NCT06972602


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-01-22 @ 4:49 AM
Study NCT ID: NCT06972602
Status: RECRUITING
Last Update Posted: 2025-05-15
First Post: 2025-05-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Sponsor: Eye & ENT Hospital of Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module